Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jeffrey M. Riggs"'
Autor:
Rachel Ettinger, Jodi L. Karnell, Jill Henault, Santosh K. Panda, Jeffrey M. Riggs, Roland Kolbeck, Miguel A. Sanjuan
Publikováno v:
Autoimmunity, Vol 50, Iss 1, Pp 25-36 (2017)
Autoantibodies of the IgG subclass are pathogenic in a number of autoimmune disorders such as systemic lupus erythomatosus. The presence of circulating IgE autoantibodies in autoimmune patients has also been known for almost 40 years. Despite their r
Externí odkaz:
https://doaj.org/article/ae21a14b0df746ca9389410b806f6814
Autor:
Gianluca Carlesso, Darren J. Schofield, Ronald Herbst, Geetha K. Bhat, Jeffrey M. Riggs, Yvonne Puplampu-Dove, Zenon Zenonos, Gareth Browne, Andrew Garcia, Tamer I. Mahmoud, Hormas Ghadially, Des C. Jones, Taeil Kim, Madhu Ramaswamy
Supplementary Table 1Suppl. Table 1 related to materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c867539694432660b7dd69219ed965
https://doi.org/10.1158/2326-6066.22544859.v1
https://doi.org/10.1158/2326-6066.22544859.v1
Autor:
Gianluca Carlesso, Darren J. Schofield, Ronald Herbst, Geetha K. Bhat, Jeffrey M. Riggs, Yvonne Puplampu-Dove, Zenon Zenonos, Gareth Browne, Andrew Garcia, Tamer I. Mahmoud, Hormas Ghadially, Des C. Jones, Taeil Kim, Madhu Ramaswamy
Supplementary Figures S1-S7Supplementary Figures S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cee7b46fd70653a2fd06bbbb1e9efe
https://doi.org/10.1158/2326-6066.22544862.v1
https://doi.org/10.1158/2326-6066.22544862.v1
Autor:
Gianluca Carlesso, Darren J. Schofield, Ronald Herbst, Geetha K. Bhat, Jeffrey M. Riggs, Yvonne Puplampu-Dove, Zenon Zenonos, Gareth Browne, Andrew Garcia, Tamer I. Mahmoud, Hormas Ghadially, Des C. Jones, Taeil Kim, Madhu Ramaswamy
Checkpoint blockade therapies targeting PD-1/PD-L1 and CTLA-4 are clinically successful but also evoke adverse events due to systemic T-cell activation. We engineered a bispecific, mAb targeting CD28 homolog (CD28H), a newly identified B7 family rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec9ec374bbda9dffe535a040c2c2b71
https://doi.org/10.1158/2326-6066.c.6550767.v1
https://doi.org/10.1158/2326-6066.c.6550767.v1
Autor:
Madhu Ramaswamy, Taeil Kim, Des C. Jones, Hormas Ghadially, Tamer I. Mahmoud, Andrew Garcia, Gareth Browne, Zenon Zenonos, Yvonne Puplampu-Dove, Jeffrey M. Riggs, Geetha K. Bhat, Ronald Herbst, Darren J. Schofield, Gianluca Carlesso
Publikováno v:
Cancer immunology research. 10(2)
Checkpoint blockade therapies targeting PD-1/PD-L1 and CTLA-4 are clinically successful but also evoke adverse events due to systemic T-cell activation. We engineered a bispecific, mAb targeting CD28 homolog (CD28H), a newly identified B7 family rece
Autor:
Jodi L. Karnell, Michael A Smith, William Rees, Victoria P. Werth, Jill Henault, Li Yan, Katherine Ann Vousden, Jeffrey M. Riggs, Miguel A. Sanjuan, Vib Trial Investigators, G. Illei, John N. Ratchford, Yanping Wu, Simone M. Nicholson, Kerry A. Casey, Nanette Mittereder, Michele Gunsior, Jorn Drappa
Publikováno v:
Science translational medicine. 13(595)
Plasmacytoid dendritic cells (pDCs) not only are specialized in their capacity to secrete large amounts of type I interferon (IFN) but also serve to enable both innate and adaptive immune responses through expression of additional proinflammatory cyt
Autor:
Dominic Sinibaldi, Ethan Grant, Rachel Ettinger, Melissa Parker, Michael A Smith, Kerry A. Casey, Michelle Petri, Devon K. Taylor, Miguel A. Sanjuan, Jodi L. Karnell, Jill Henault, Jeffrey M. Riggs, Roland Kolbeck
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Systemic lupus erythematosus (SLE) impacts multiple organ systems, although the causes of many individual SLE pathologies are poorly understood. This study was designed to elucidate organ-specific inflammation by identifying proteins that correlate w
Autor:
Desmond Jones, Tamer Mahmoud, Madhu Ramaswamy, Susan Wilson, Gianluca Carlesso, Jeffrey M. Riggs, Andrew Garcia, Hormas Ghadially, Darren J. Schofield, Taeil Kim
Publikováno v:
Cancer Research. 80:4438-4438
The success of immune checkpoint inhibitors CTLA4 and PD-1 monoclonal antibody, both FDA approved cancer therapies, specifically counteracts inhibitory pathways to activate antigen-specific T cells. However, their success is limited by the fact that
Autor:
Jill Henault, Roland Kolbeck, Santosh K. Panda, Jeffrey M. Riggs, Rachel Ettinger, Jodi L. Karnell, Miguel A. Sanjuan
Publikováno v:
Autoimmunity. 50(1)
Autoantibodies of the IgG subclass are pathogenic in a number of autoimmune disorders such as systemic lupus erythomatosus. The presence of circulating IgE autoantibodies in autoimmune patients has also been known for almost 40 years. Despite their r
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Autor:
William Vermi, Miguel A. Sanjuan, Sarah L. Rowland, Jeffrey M. Riggs, Susan Gilfillan, Emil R. Unanue, Roland Kolbeck, Marco Colonna, Mattia Bugatti
Publikováno v:
Journal of Experimental Medicine. 211:1977-1991
Plasmacytoid dendritic cells (pDCs) have long been implicated in the pathogenesis of lupus. However, this conclusion has been largely based on a correlative link between the copious production of IFN-α/β by pDCs and the IFN-α/β “signature” of